RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Lilia Kucheryavykh to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Lilia Kucheryavykh has written about Dose-Response Relationship, Drug.
Lilia Kucheryavykh
Connection Strength
0.215
Dose-Response Relationship, Drug
  1. Del Valle MM, Colon EM, Kettimuthu K, Maner-Smith K, Olson JJ, Kucheryavykh LY. Window of opportunity study measuring defactinib and avutometinib delivery in glioblastomas. Cancer Chemother Pharmacol. 2026 Mar 06; 96(1).
    View in: PubMed
    Score: 0.192
  2. Rivera-Aponte DE, M?ndez-Gonz?lez MP, Rivera-Pag?n AF, Kucheryavykh YV, Kucheryavykh LY, Skatchkov SN, Eaton MJ. Hyperglycemia reduces functional expression of astrocytic Kir4.1 channels and glial glutamate uptake. Neuroscience. 2015 Dec 03; 310:216-23.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support